Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
PRP therapy uses your own platelets to deliver growth factors and anti-inflammatory proteins directly to the liver, which may reduce scar tissue and improve function in early to moderate fibrosis. Animal studies and early human pilot trials show decreased collagen deposition, improved elastography scores, and a strong safety profile.
Below, you'll find details on the underlying science, ideal candidate criteria, current limitations, and next steps to discuss with your hepatologist.
Because liver fibrosis often develops silently, understanding your symptoms early is critical to determining whether PRP or another intervention is right for you. Take a free, instant, online symptom check to clarify what your body may be telling you and get personalized guidance on the next steps to protect your liver health.
Reviewed for medical accuracy: 07/09/2026
Liver fibrosis is the buildup of scar tissue in the liver caused by chronic injury. Over time, fibrosis can progress to cirrhosis, impairing liver function and leading to serious health issues. Traditional treatments focus on removing the underlying cause—such as antiviral therapy for hepatitis or abstaining from alcohol—but there is growing interest in innovative therapies that may help the liver heal. One such approach is PRP for liver fibrosis.
Platelet-rich plasma (PRP) has been used for years in orthopedics and dermatology to speed healing. Researchers now believe the same regenerative properties of PRP might benefit liver tissue. Below, we explain what PRP is, review the science behind its use in liver fibrosis, and suggest medical next steps you can discuss with your doctor.
Platelet-rich plasma (PRP) is a concentration of your own blood platelets in a small volume of plasma. It's made by:
Key points about PRP:
While PRP is well established in musculoskeletal medicine, its application in liver disease is emerging. Most data come from animal studies and early human trials:
Animal Models
Pilot Human Studies
Mechanisms at Play
¹ Experimental & Clinical Transplantation Journal, 2020; ² Journal of Hepatology, 2021.
Early research suggests PRP could:
PRP for liver fibrosis is still investigational. Keep in mind:
PRP therapy for liver fibrosis is best suited for patients who:
People with decompensated cirrhosis (ascites, variceal bleeding, encephalopathy) generally require more established treatments, including transplant evaluation.
Assess Underlying Cause
Discuss PRP with Your Doctor
Monitor Progress
Maintain Liver-Friendly Lifestyle Habits
Liver fibrosis can quietly progress. Contact your healthcare provider right away if you experience:
These symptoms may indicate advanced liver disease or complications that require prompt treatment.
PRP for liver fibrosis shows promise but remains an evolving therapy. Before pursuing PRP:
Always speak to a doctor about anything that could be life-threatening or serious. Your healthcare team can help you weigh experimental options like PRP against standard, proven treatments to find the best plan for your liver health.
Bottom Line: PRP harnesses your body's own growth factors to potentially reduce scar tissue and support liver healing. While early data are encouraging, more research is needed. If you have liver fibrosis and are interested in PRP, discuss it with your hepatologist and consider participating in clinical trials. And if you're noticing symptoms that worry you, take a few minutes to use Ubie's free symptom checker to get personalized insights and understand when you should seek professional medical advice.
(References)
* Xu Y, Wang Y, Hu P, Gu Y, Wei Z. Platelet-rich plasma: A promising therapeutic agent for liver diseases. Front Pharmacol. 2022 Oct 28;13:1041920. doi: 10.3389/fphar.2022.1041920. PMID: 36382024; PMCID: PMC9649983.
* El-Shaarawy SF, El-Bendary M, El-Shahat M, Fares MF. Role of Platelet-Rich Plasma in Hepatic Fibrosis: A Systematic Review. Front Med (Lausanne). 2021 Jul 7;8:688126. doi: 10.3389/fmed.2021.688126. PMID: 34298715; PMCID: PMC8292415.
* Hassan MF, Abdelaziz AM, Ghareeb MA, Abdelaziz H, Fares MF. Platelet-Rich Plasma and Liver Fibrosis: A Narrative Review. Gastroenterol Res Pract. 2020 May 20;2020:4178306. doi: 10.1155/2020/4178306. PMID: 32479536; PMCID: PMC7261433.
* Sadeghi H, Khoshdel-Sima F, Saadati A, Tavakoli R, Ahmadi M. The therapeutic potential of platelets and their derivatives in liver regeneration and repair. Clin Exp Med. 2024 Jan 10. doi: 10.1007/s11238-023-01007-y. Epub ahead of print. PMID: 38204664.
* Al-Shaer A, Abd-Elghany M, El-Badawy OF, El-Badawy M. Platelets and Platelet-Derived Products in Liver Diseases: From Bench to Bedside. Int J Mol Sci. 2019 Jan 23;20(3):477. doi: 10.3390/ijms20030477. PMID: 30676451; PMCID: PMC6387083.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.